GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Inventories, Raw Materials & Components

Yumanity Therapeutics (FRA:8IY) Inventories, Raw Materials & Components : €0.00 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Inventories, Raw Materials & Components?

Yumanity Therapeutics's inventories, raw materials & components for the quarter that ended in Sep. 2022 was €0.00 Mil.


Yumanity Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Yumanity Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Inventories, Raw Materials & Components Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Inventories, Raw Materials & Components
- - -

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Yumanity Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Yumanity Therapeutics (FRA:8IY) Business Description

Industry
Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines